Drug Shortage Report for TEVA-SIMVASTATIN

Last updated on 2020-06-05 History
Report ID 104319
Drug Identification Number 02250144
Brand name TEVA-SIMVASTATIN
Common or Proper name SIMVASTATIN 5MG TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) SIMVASTATIN
Strength(s) 5MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100's & PP 30's
ATC code C10AA
ATC description LIPID MODIFYING AGENTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-22
Estimated end date Unknown
Actual end date 2020-06-04
Shortage status Resolved
Updated date 2020-06-05
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-06-05 English Compare
v4 2020-06-04 French Compare
v3 2020-06-04 English Compare
v2 2020-01-24 French Compare
v1 2020-01-24 English Compare